SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-040193
Filing Date
2023-11-13
Accepted
2023-11-09 21:22:18
Documents
5
Period of Report
2023-11-09

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 175640
2 formdef14a_003.jpg GRAPHIC 4678
3 formdef14a_004.jpg GRAPHIC 1403
4 formdef14a_001.jpg GRAPHIC 226282
5 formdef14a_002.jpg GRAPHIC 260928
  Complete submission text file 0001493152-23-040193.txt   856561
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38306 | Film No.: 231394402
SIC: 2834 Pharmaceutical Preparations